Valarie Truax, PhD., MBA, has recently joined the Office of Cooperative Research as a Licensing Associate where she will help to guide Yale’s promising research on the path to commercialization. As a PhD student at Emory University under the direction of chemistry professor Dennis Liotta, Valarie was actively involved in the synthesis and biological evaluation of CXCR4 antagonists for HIV and cancer. She later worked on a Joint Research Collaboration with Bristol-Myers Squibb and the Liotta lab for the design on novel CXCR4 antagonists for cancer as a post-doctoral fellow.
Merging her passion for both science and business, Valarie also completed a joint MBA degree at Emory. She was named Emerging Leader of the Year by Georgia Bio in 2012 which honors young professionals for outstanding contributions to the success of the Emerging Leaders Network and the growth of Georgia’s life sciences community. Valerie received her MS in Biochemistry and Molecular Biology from Georgetown University.
“I’m thrilled to take an active role in commercializing Yale’s groundbreaking science as part of the OCR team,” Valerie says. “There is such incredible innovation and discovery happening at Yale with the potential to really make an impact.”
CONTACT: Brita Belli, Communications Officer, Yale Innovation & Entrepreneurship, (203) 804-1911, email@example.com.